PF-06446846

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NamePF-06446846

Drug Alias NamePF-06446846

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsHypercholesterolemia

Inactive IndicationsN/A

ATC CodeN/A